/Companies

Zymenex

Acquired

1 known investors

Find your way into Zymenex

Sign up to see every warm intro you have to Zymenex

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Zymenex team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Acquired by Chiesi Group August 2013 · terms undisclosed — Terms not disclosed · source ↗

Zymenex was a Danish biopharmaceutical company developing enzyme replacement therapies, such as Lamazym, for rare lysosomal storage diseases like alpha-mannosidosis.

Investors · 1

Founder mafia

2 people who came through Zymenex went on to found or lead other companies.

Frequently asked questions

What does Zymenex do?
Zymenex was a Danish biopharmaceutical company developing enzyme replacement therapies, such as Lamazym, for rare lysosomal storage diseases like alpha-mannosidosis.
Who are Zymenex's investors?
Zymenex's investors include Sunstone Capital.